Senior Director Market Access Inline Immunoglobulins (IG)

Senior Director Market Access Inline Immunoglobulins (IG) Employer CSL Location King of Prussia, PA Start date Jun 6, 2026 View more categories View less categories Discipline Marketing , Market Access Required Education Masters Degree/MBA Position Type Full time Hotbed Pharm Country , Best Places to Work Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job

Job Details Company Job Details Role Overview:

The Senior Director of Market Access for Inline Assets will be responsible for shaping and implementing market access strategies for CSL Behring inline assets. This role is accountable for maximizing the asset total life cycle value throughout product life cycle. It requires strong expertise in obtaining, sustaining, and optimizing product pricing & reimbursement, and a comprehensive understanding of the payer environment in key international markets.

Key Responsibilities:

• Lead the Market Access inline team in one Therapeutic Areas (TAs). Build, mentor, and lead a high-performing global market access inline team, fostering a culture of collaboration, innovation, inclusion, and accountability.
• Serve as a key member of the global Market Access Leadership Team (MALT), contributing to the development and execution of functional strategy, operations, and capability building.
• Accountable for Market Access deliverables during the inline phase, continuously refining and improving standards for these deliverables.
• Collaborate with Medical Affairs, Marketing, and other partner functions to influence brand strategy and execution, ensuring proper integration of market access considerations.
• Keep abreast with payer policies and regulations, economic data within the assigned TA in key international markets. Identify market access opportunities and risks, capture opportunities, mitigate risks through proactive planning, scenario analysis, and stakeholder engagement.
• Deliver and periodically update the Global Value Dossier as a foundational document for affiliate Pricing & Reimbursement (P&R) and Health Technology Assessment (HTA) submissions and resubmissions.
• Provide guidance and support to country teams in P&R and HTA submissions, negotiations, and authority responses, ensuring alignment with global strategies.
• Optimize payer value propositions (PVPs) and health economic models to effectively communicate the clinical and economic value of inline assets to payers and other key stakeholders.
• Continuously drive the development of lifecycle payer evidence and optimize pricing strategies to maintain and enhance P&R throughout the product lifecycle.
• Provide systematic market access insights for forecasting and long-range planning, including analysis of key payer policy changes, risk assessments, and opportunity identification.
• Represent CSL at global trade associations, participating in access-related committees and working groups to influence industry standards and practices.

Qualifications:

• At least 12 years of experience in market access, with significant exposure to diverse healthcare systems in the international markets.
• Proven track record of leading and developing high-performing teams in a global, crossfunctional environment. A role model of collaboration, innovation, inclusion, and accountability.
• Proven track record in obtaining, sustaining, and optimizing pricing, reimbursement, and patient access across diverse healthcare systems in international markets.
• Extensive knowledge of global healthcare systems, payer landscapes, and the interplay between market access and international markets.
• Proven ability to deliver superior performance across diverse healthcare systems in the international markets.
• An advanced degree in Health Economics, Public Health, or a related field is required.

About CSL Vifor CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in irondeficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care). The parent company,CSL, headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries. To learn more about

CSL, CSL

Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ . Our Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL . You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement . Company CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL - including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor - provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Areas of Expertise We focus and demonstrate global leadership in three distinct areas—rare and serious diseases; influenza vaccines; and iron deficiency and nephrology. Rare & Serious Diseases CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Vaccines As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries. Iron Deficiency & Nephrology With our iron deficiency and iron deficiency anemia expertise in heart failure, kidney disease, gastroenterology or inflammatory bowel disease, patient blood management and women's health, we help patients affected by these conditions to live better, healthier lives. Company info Phone 610-878-4000 Location 1020 First Avenue King of Prussia Pennsylvania 19406 United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert